Assunta Bianco

1.5k total citations
36 papers, 977 citations indexed

About

Assunta Bianco is a scholar working on Pathology and Forensic Medicine, Immunology and Oncology. According to data from OpenAlex, Assunta Bianco has authored 36 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Pathology and Forensic Medicine, 15 papers in Immunology and 9 papers in Oncology. Recurrent topics in Assunta Bianco's work include Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (5 papers). Assunta Bianco is often cited by papers focused on Multiple Sclerosis Research Studies (23 papers), Peripheral Neuropathies and Disorders (5 papers) and Polyomavirus and related diseases (5 papers). Assunta Bianco collaborates with scholars based in Italy, Austria and United States. Assunta Bianco's co-authors include Hans Lassmann, Massimiliano Mirabella, Viviana Nociti, Giovanni Frisullo, Raffaele Iorio, Agata Katia Patanella, Anna Paola Batocchi, Matteo Lucchini, Pietro Tonali and Alessandro Marti and has published in prestigious journals such as PLoS ONE, Biomaterials and Annals of Neurology.

In The Last Decade

Assunta Bianco

36 papers receiving 964 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Assunta Bianco Italy 18 382 295 259 155 140 36 977
Damacio Ramón Kaimen-Maciel Brazil 19 684 1.8× 262 0.9× 220 0.8× 131 0.8× 124 0.9× 39 1.1k
Tobias V. Lanz United States 17 134 0.4× 397 1.3× 333 1.3× 166 1.1× 190 1.4× 28 1.2k
Nikolaos Kostulas Sweden 12 250 0.7× 701 2.4× 215 0.8× 380 2.5× 191 1.4× 13 1.3k
Faiez Al Nimer Sweden 22 403 1.1× 304 1.0× 447 1.7× 247 1.6× 115 0.8× 47 1.3k
Yuli Liu China 17 143 0.4× 210 0.7× 735 2.8× 102 0.7× 148 1.1× 36 1.4k
Berta Martins da Silva Portugal 20 257 0.7× 371 1.3× 320 1.2× 52 0.3× 105 0.8× 57 1.3k
Roberto Bomprezzi United States 12 239 0.6× 212 0.7× 396 1.5× 59 0.4× 123 0.9× 24 973
Hongtao Sun Canada 25 93 0.2× 407 1.4× 648 2.5× 78 0.5× 83 0.6× 47 1.9k
Valeria Muzio Italy 15 87 0.2× 156 0.5× 191 0.7× 64 0.4× 174 1.2× 22 660

Countries citing papers authored by Assunta Bianco

Since Specialization
Citations

This map shows the geographic impact of Assunta Bianco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Assunta Bianco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Assunta Bianco more than expected).

Fields of papers citing papers by Assunta Bianco

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Assunta Bianco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Assunta Bianco. The network helps show where Assunta Bianco may publish in the future.

Co-authorship network of co-authors of Assunta Bianco

This figure shows the co-authorship network connecting the top 25 collaborators of Assunta Bianco. A scholar is included among the top collaborators of Assunta Bianco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Assunta Bianco. Assunta Bianco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bsteh, Gabriel, Assunta Bianco, Tobias Zrzavy, & Thomas Berger. (2024). Novel and Emerging Treatments to Target Pathophysiological Mechanisms in Various Phenotypes of Multiple Sclerosis. Pharmacological Reviews. 76(4). 564–578. 2 indexed citations
2.
Plantone, Domenico, Mariano Marrodán, Sini M. Laakso, et al.. (2023). Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome. European Journal of Neurology. 30(10). 3256–3264. 2 indexed citations
3.
Lucchini, Matteo, Paola Del Giacomo, Valeria De Arcangelis, et al.. (2022). The Expanding Role of the Infectious Disease Expert in the Context of the MS Centre. Journal of Personalized Medicine. 12(4). 591–591. 1 indexed citations
4.
Lucchini, Matteo, Valeria De Arcangelis, Geny Piro, et al.. (2022). CSF CXCL13 and Chitinase 3-like-1 Levels Predict Disease Course in Relapsing Multiple Sclerosis. Molecular Neurobiology. 60(1). 36–50. 24 indexed citations
5.
Pozzilli, Valeria, Fioravante Capone, Francesco Motolese, et al.. (2022). A true isolated cognitive relapse in multiple sclerosis. Neurological Sciences. 44(1). 339–342. 2 indexed citations
6.
Lucchini, Matteo, Viviana Nociti, Assunta Bianco, et al.. (2021). Defining the disease course of TNFα blockers-associated Multiple Sclerosis. Journal of Neuroimmunology. 353. 577525–577525. 3 indexed citations
7.
Bianco, Assunta, Matteo Lucchini, Rocco Totaro, et al.. (2021). Disease Reactivation after Fingolimod Discontinuation in Pregnant Multiple Sclerosis Patients. Neurotherapeutics. 18(4). 2598–2607. 16 indexed citations
8.
Biolato, Marco, Assunta Bianco, Matteo Lucchini, et al.. (2021). The Disease-Modifying Therapies of Relapsing-Remitting Multiple Sclerosis and Liver Injury: A Narrative Review. CNS Drugs. 35(8). 861–880. 28 indexed citations
9.
Capone, Fioravante, Matteo Lucchini, Elisabetta Ferraro, et al.. (2021). Immunogenicity and safety of mRNA COVID-19 vaccines in people with multiple sclerosis treated with different disease-modifying therapies. Neurotherapeutics. 19(1). 325–333. 33 indexed citations
10.
Bianco, Assunta, Anna Rita Larici, Matteo Lucchini, et al.. (2019). Alemtuzumab-induced lung injury in multiple sclerosis: Learning from adversity in three patients. Multiple Sclerosis and Related Disorders. 37. 101450–101450. 6 indexed citations
11.
Fino, Chiara De, Matteo Lucchini, Donatella Lucchetti, et al.. (2019). The predictive value of CSF multiple assay in multiple sclerosis: A single center experience. Multiple Sclerosis and Related Disorders. 35. 176–181. 19 indexed citations
12.
Grimaldi, Alessandro, Laura De Giglio, Shalom Haggiag, et al.. (2019). The influence of physiotherapy intervention on patients with multiple sclerosis–related spasticity treated with nabiximols (THC:CBD oromucosal spray). PLoS ONE. 14(7). e0219670–e0219670. 8 indexed citations
13.
Santoro, Massimo, Massimiliano Mirabella, Chiara De Fino, et al.. (2017). Sativex® effects on promoter methylation and on CNR1 / CNR2 expression in peripheral blood mononuclear cells of progressive multiple sclerosis patients. Journal of the Neurological Sciences. 379. 298–303. 12 indexed citations
14.
Prosperini, Luca, Francesco Saccà, Cinzia Cordioli, et al.. (2016). Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis. Journal of Neurology. 264(2). 284–294. 41 indexed citations
15.
Bianco, Assunta, Agata Katia Patanella, Viviana Nociti, et al.. (2014). Second-Line Therapy with Fingolimod for Relapsing-Remitting Multiple Sclerosis in Clinical Practice: The Effect of Previous Exposure to Natalizumab. European Neurology. 73(1-2). 57–65. 18 indexed citations
16.
Plantone, Domenico, Alessandro Marti, Giovanni Frisullo, et al.. (2013). Circulating CD56dim NK cells expressing perforin are increased in progressive multiple sclerosis. Journal of Neuroimmunology. 265(1-2). 124–127. 33 indexed citations
17.
Frisullo, Giovanni, Domenico Plantone, Alessandro Marti, et al.. (2012). Type 1 immune response in progressive multiple sclerosis. Journal of Neuroimmunology. 249(1-2). 112–116. 13 indexed citations
18.
Frisullo, Giovanni, Roberto Frusciante, Viviana Nociti, et al.. (2010). CD8+ T Cells in Facioscapulohumeral Muscular Dystrophy Patients with Inflammatory Features at Muscle MRI. Journal of Clinical Immunology. 31(2). 155–166. 107 indexed citations
19.
Andersson, Åsa, Ruxandra Covacu, Dan Sunnemark, et al.. (2008). Pivotal Advance: HMGB1 expression in active lesions of human and experimental multiple sclerosis. Journal of Leukocyte Biology. 84(5). 1248–1255. 181 indexed citations
20.
Frisullo, Giovanni, Viviana Nociti, Raffaele Iorio, et al.. (2007). Glucocorticoid treatment reduces T-bet and pSTAT1 expression in mononuclear cells from relapsing remitting multiple sclerosis patients. Clinical Immunology. 124(3). 284–293. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Damacio Ramón Kaimen-Maciel Breakdown of academic impact, for papers by Tobias V. Lanz Breakdown of academic impact, for papers by Nikolaos Kostulas Breakdown of academic impact, for papers by Faiez Al Nimer Breakdown of academic impact, for papers by Yuli Liu Breakdown of academic impact, for papers by Berta Martins da Silva Breakdown of academic impact, for papers by Roberto Bomprezzi Breakdown of academic impact, for papers by Hongtao Sun Breakdown of academic impact, for papers by Valeria Muzio
Rankless by CCL
2026